153 related articles for article (PubMed ID: 10362357)
21. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation.
Arron JR; Vologodskaia M; Wong BR; Naramura M; Kim N; Gu H; Choi Y
J Biol Chem; 2001 Aug; 276(32):30011-7. PubMed ID: 11406619
[TBL] [Abstract][Full Text] [Related]
22. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.
Keane MM; Rivero-Lezcano OM; Mitchell JA; Robbins KC; Lipkowitz S
Oncogene; 1995 Jun; 10(12):2367-77. PubMed ID: 7784085
[TBL] [Abstract][Full Text] [Related]
24. CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2.
Husson H; Mograbi B; Schmid-Antomarchi H; Fischer S; Rossi B
Oncogene; 1997 May; 14(19):2331-8. PubMed ID: 9178909
[TBL] [Abstract][Full Text] [Related]
25. The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction.
Kirsch KH; Georgescu MM; Shishido T; Langdon WY; Birge RB; Hanafusa H
J Biol Chem; 2001 Feb; 276(7):4957-63. PubMed ID: 11067845
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
27. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor.
Bartkiewicz M; Houghton A; Baron R
J Biol Chem; 1999 Oct; 274(43):30887-95. PubMed ID: 10521482
[TBL] [Abstract][Full Text] [Related]
28. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
Blake TJ; Shapiro M; Morse HC; Langdon WY
Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
[TBL] [Abstract][Full Text] [Related]
29. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
30. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.
Lupher ML; Rao N; Lill NL; Andoniou CE; Miyake S; Clark EA; Druker B; Band H
J Biol Chem; 1998 Dec; 273(52):35273-81. PubMed ID: 9857068
[TBL] [Abstract][Full Text] [Related]
31. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
32. cbl-b inhibits epidermal growth factor receptor signaling.
Ettenberg SA; Keane MM; Nau MM; Frankel M; Wang LM; Pierce JH; Lipkowitz S
Oncogene; 1999 Mar; 18(10):1855-66. PubMed ID: 10086340
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase.
Hunter S; Koch BL; Anderson SM
Mol Endocrinol; 1997 Aug; 11(9):1213-22. PubMed ID: 9259313
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.
Elly C; Witte S; Zhang Z; Rosnet O; Lipkowitz S; Altman A; Liu YC
Oncogene; 1999 Feb; 18(5):1147-56. PubMed ID: 10022120
[TBL] [Abstract][Full Text] [Related]
36. The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins.
Flanders JA; Feng Q; Bagrodia S; Laux MT; Singavarapu A; Cerione RA
FEBS Lett; 2003 Aug; 550(1-3):119-23. PubMed ID: 12935897
[TBL] [Abstract][Full Text] [Related]
37. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
[TBL] [Abstract][Full Text] [Related]
38. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
39. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
Kyono WT; de Jong R; Park RK; Liu Y; Heisterkamp N; Groffen J; Durden DL
J Immunol; 1998 Nov; 161(10):5555-63. PubMed ID: 9820532
[TBL] [Abstract][Full Text] [Related]
40. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl.
Wong A; Lamothe B; Lee A; Schlessinger J; Lax I
Proc Natl Acad Sci U S A; 2002 May; 99(10):6684-9. PubMed ID: 11997436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
